Medical devices, healthcare technology and the business of care
510(k) clearance · K252486

ChestView US (1.1)

Gleamer · Decision date Sep 9, 2026

MEDTECHLEDGER EXPLANATIONK252486

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 9, 2026 for ChestView US (1.1), a Gleamer radiological computer-assisted detection software device (21 CFR 892.2070, Class II, product code MYN, radiology panel). The submission is a traditional 510(k), K252486, with a Predetermined Change Control Plan authorized; the listed predicate is ChestView US, K241620. SESE is a clearance to market, not premarket approval. The public record shows a received date of 08/07/2025 on the database page, while the clearance letter cites August 10, 2026 for dating and receipt; the discrepancy is unresolved in the public information.

The summary describes software that marks regions of interest on frontal and lateral chest radiographs as Nodule, Consolidation, Pleural Space Abnormality, or Mediastinum/Hila Abnormality, with bounding-box styling tied to algorithm confidence, and states it is a concurrent reading aid for radiologists and emergency medicine physicians, prescription-only and for adults. The changed item is the model version relative to predicate 1.0. The summary states a modified model is deployed only if it meets all comparison non-inferiority criteria against both comparators and all primary-endpoint standalone criteria. Standalone performance results, the specific model changes, and the authorized change-control plan contents are not provided in the supplied excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 9, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K252486
Regulatory pathway
510(k) premarket notification
Applicant
Gleamer
Product code
MYN
Decision code
SESE
Decision date
Sep 9, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Analyzer, Medical Image.

Applicant
Gleamer
Product code
MYN
FDA device class
2

FDA decision timeline

  1. K252486 received

    Application receipt date recorded by FDA.

  2. K252486 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MYN

Product / regulatory recordCompanyPathwayDecision dateSource
Dentsply Sirona, Inc.510(k) clearanceOct 30, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Gleamer

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Paris

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records